JP2011162556A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011162556A5 JP2011162556A5 JP2011109756A JP2011109756A JP2011162556A5 JP 2011162556 A5 JP2011162556 A5 JP 2011162556A5 JP 2011109756 A JP2011109756 A JP 2011109756A JP 2011109756 A JP2011109756 A JP 2011109756A JP 2011162556 A5 JP2011162556 A5 JP 2011162556A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- medicament
- ion
- disease
- dry powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 8
- 239000003814 drug Substances 0.000 claims 6
- 229940112141 dry powder inhaler Drugs 0.000 claims 4
- -1 benzenesulfonate ion Chemical class 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 206010006458 Bronchitis chronic Diseases 0.000 claims 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 2
- 206010014561 Emphysema Diseases 0.000 claims 2
- 102000014415 Muscarinic acetylcholine receptor Human genes 0.000 claims 2
- 108050003473 Muscarinic acetylcholine receptor Proteins 0.000 claims 2
- 206010061876 Obstruction Diseases 0.000 claims 2
- 206010039085 Rhinitis allergic Diseases 0.000 claims 2
- 201000010105 allergic rhinitis Diseases 0.000 claims 2
- 208000006673 asthma Diseases 0.000 claims 2
- 206010006451 bronchitis Diseases 0.000 claims 2
- 208000007451 chronic bronchitis Diseases 0.000 claims 2
- 230000001684 chronic effect Effects 0.000 claims 2
- 229940071648 metered dose inhaler Drugs 0.000 claims 2
- 208000005069 pulmonary fibrosis Diseases 0.000 claims 2
- 230000000241 respiratory effect Effects 0.000 claims 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical group CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 claims 1
- 229960004373 acetylcholine Drugs 0.000 claims 1
- 150000001450 anions Chemical class 0.000 claims 1
- 229940077388 benzenesulfonate Drugs 0.000 claims 1
- 229940006460 bromide ion Drugs 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 claims 1
- 229940006461 iodide ion Drugs 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 0 CC(*)(*)CC1(CC(CC2)N(C)C2C1)NC Chemical compound CC(*)(*)CC1(CC(CC2)N(C)C2C1)NC 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51100903P | 2003-10-14 | 2003-10-14 | |
| US60/511,009 | 2003-10-14 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007201718A Division JP4796552B2 (ja) | 2003-10-14 | 2007-08-02 | ムスカリン性アセチルコリン受容体アンタゴニスト |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011162556A JP2011162556A (ja) | 2011-08-25 |
| JP2011162556A5 true JP2011162556A5 (https=) | 2012-08-09 |
| JP5450509B2 JP5450509B2 (ja) | 2014-03-26 |
Family
ID=34465175
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006535591A Pending JP2007508390A (ja) | 2003-10-14 | 2004-10-12 | ムスカリン性アセチルコリン受容体アンタゴニスト |
| JP2007201718A Expired - Fee Related JP4796552B2 (ja) | 2003-10-14 | 2007-08-02 | ムスカリン性アセチルコリン受容体アンタゴニスト |
| JP2007201719A Pending JP2007314567A (ja) | 2003-10-14 | 2007-08-02 | ムスカリン性アセチルコリン受容体アンタゴニスト |
| JP2011109756A Expired - Fee Related JP5450509B2 (ja) | 2003-10-14 | 2011-05-16 | ムスカリン性アセチルコリン受容体アンタゴニスト |
Family Applications Before (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006535591A Pending JP2007508390A (ja) | 2003-10-14 | 2004-10-12 | ムスカリン性アセチルコリン受容体アンタゴニスト |
| JP2007201718A Expired - Fee Related JP4796552B2 (ja) | 2003-10-14 | 2007-08-02 | ムスカリン性アセチルコリン受容体アンタゴニスト |
| JP2007201719A Pending JP2007314567A (ja) | 2003-10-14 | 2007-08-02 | ムスカリン性アセチルコリン受容体アンタゴニスト |
Country Status (34)
| Country | Link |
|---|---|
| US (3) | US7276521B2 (https=) |
| EP (1) | EP1677795B1 (https=) |
| JP (4) | JP2007508390A (https=) |
| KR (3) | KR20080067023A (https=) |
| CN (3) | CN101230061A (https=) |
| AP (3) | AP1828A (https=) |
| AR (1) | AR046103A1 (https=) |
| AT (1) | ATE494285T1 (https=) |
| AU (1) | AU2004281724B2 (https=) |
| BR (1) | BRPI0415361A (https=) |
| CA (1) | CA2542657C (https=) |
| CY (1) | CY1111364T1 (https=) |
| DE (1) | DE602004030930D1 (https=) |
| DK (1) | DK1677795T3 (https=) |
| EA (3) | EA200600773A1 (https=) |
| EC (1) | ECSP066468A (https=) |
| ES (1) | ES2358673T3 (https=) |
| HR (1) | HRP20110232T1 (https=) |
| IL (2) | IL174843A0 (https=) |
| IS (1) | IS2918B (https=) |
| MA (1) | MA28110A1 (https=) |
| MX (1) | MXPA06004244A (https=) |
| MY (1) | MY143366A (https=) |
| NO (1) | NO20062042L (https=) |
| NZ (2) | NZ556424A (https=) |
| OA (1) | OA13316A (https=) |
| PE (1) | PE20050963A1 (https=) |
| PL (1) | PL1677795T3 (https=) |
| PT (1) | PT1677795E (https=) |
| SG (1) | SG147436A1 (https=) |
| SI (1) | SI1677795T1 (https=) |
| TW (3) | TW200811171A (https=) |
| UA (2) | UA89734C2 (https=) |
| WO (1) | WO2005037280A1 (https=) |
Families Citing this family (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20050250A1 (es) * | 2003-07-17 | 2005-04-08 | Glaxo Group Ltd | Antagonistas de los receptores muscarinicos de la acetilcolina |
| WO2005037280A1 (en) * | 2003-10-14 | 2005-04-28 | Glaxo Group Limited | Muscarinic acetycholine receptor antagonists |
| AU2004281167A1 (en) * | 2003-10-17 | 2005-04-28 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists field of the invention |
| PE20050489A1 (es) * | 2003-11-04 | 2005-09-02 | Glaxo Group Ltd | Antagonistas de receptores de acetilcolina muscarinicos |
| WO2005087236A1 (en) * | 2004-03-11 | 2005-09-22 | Glaxo Group Limited | Novel m3 muscarinic acetylcholine receptor antagonists |
| JP2007529513A (ja) * | 2004-03-17 | 2007-10-25 | グラクソ グループ リミテッド | Ｍ３ムスカリン性アセチルコリン受容体アンタゴニスト |
| EP1725238A4 (en) * | 2004-03-17 | 2009-04-01 | Glaxo Group Ltd | M 3 MUSCARINACETYLCHOLINE RECEPTOR ANTAGONISTS |
| UY28871A1 (es) | 2004-04-27 | 2005-11-30 | Glaxo Group Ltd | Antagonistas del receptor de acetilcolina muscarinico |
| EP1747219A4 (en) * | 2004-05-13 | 2010-05-26 | Glaxo Group Ltd | Antagonists of muscarinic acetylcholine receptor |
| WO2006055553A2 (en) * | 2004-11-15 | 2006-05-26 | Glaxo Group Limited | Novel m3 muscarinic acetylcholine receptor antagonists |
| EP1937267A4 (en) * | 2005-08-02 | 2009-08-26 | Glaxo Group Ltd | M3-MUSCARIN ACETYLCHOLIN RECEPTOR ANTAGONISTS |
| WO2007022351A2 (en) * | 2005-08-18 | 2007-02-22 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
| MX2008013411A (es) | 2006-04-20 | 2008-11-04 | Glaxo Group Ltd | Nuevos compuestos. |
| GB0611587D0 (en) | 2006-06-12 | 2006-07-19 | Glaxo Group Ltd | Novel compounds |
| PL2046787T3 (pl) | 2006-08-01 | 2011-10-31 | Glaxo Group Ltd | Związki pirazolo[3,4-b]pirydynowe i ich zastosowanie jako inhibitory PDE4 |
| CN101663262B (zh) | 2006-12-01 | 2014-03-26 | 百时美施贵宝公司 | 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物 |
| PE20081889A1 (es) | 2007-03-23 | 2009-03-05 | Smithkline Beecham Corp | Indol carboxamidas como inhibidores de ikk2 |
| EP2197444A1 (en) * | 2007-09-12 | 2010-06-23 | Glaxo Group Limited | Novel combination of therapeutic agents |
| UY31636A1 (es) | 2008-02-06 | 2009-08-03 | Farmacoforos duales-antagonistas muscarinicos de pde4 | |
| AR070562A1 (es) | 2008-02-06 | 2010-04-21 | Glaxo Group Ltd | Farmacoforos duales - antagonistas muscarinicos de pde4 |
| PE20091553A1 (es) | 2008-02-06 | 2009-10-30 | Glaxo Group Ltd | Farmacoforos duales - antagonistas muscarinicos de pde4 |
| ES2383246T3 (es) | 2008-06-05 | 2012-06-19 | Glaxo Group Limited | 4-amino-indazoles |
| US8163743B2 (en) | 2008-06-05 | 2012-04-24 | GlaxoGroupLimited | 4-carboxamide indazole derivatives useful as inhibitors of PI3-kinases |
| WO2010094643A1 (en) | 2009-02-17 | 2010-08-26 | Glaxo Group Limited | Quinoline derivatives and their uses for rhinitis and urticaria |
| DK2400950T3 (da) | 2009-02-26 | 2019-07-29 | Glaxo Group Ltd | Farmaceutiske formuleringer omfattende 4-{(1 r)-2-[(6-{2-[(2,6-dichlorbenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol |
| WO2010097114A1 (en) * | 2009-02-26 | 2010-09-02 | Glaxo Group Limited | Novel combination of therapeutic agents |
| JP5656880B2 (ja) | 2009-03-09 | 2015-01-21 | グラクソ グループ リミテッドＧｌａｘｏ Ｇｒｏｕｐ Ｌｉｍｉｔｅｄ | Ｐｉ３キナーゼの阻害剤としての４−オキサジアゾール−２−イル−インダゾール |
| WO2010102968A1 (en) | 2009-03-10 | 2010-09-16 | Glaxo Group Limited | Indole derivatives as ikk2 inhibitors |
| EP2408769A1 (en) | 2009-03-17 | 2012-01-25 | Glaxo Group Limited | Pyrimidine derivatives used as itk inhibitors |
| LT2899191T (lt) | 2009-04-30 | 2017-10-25 | Glaxo Group Limited | Oksazolo pakeistieji indazolai kaip pi3-kinazės inhibitoriai |
| GB0921075D0 (en) | 2009-12-01 | 2010-01-13 | Glaxo Group Ltd | Novel combination of the therapeutic agents |
| WO2011067364A1 (en) | 2009-12-03 | 2011-06-09 | Glaxo Group Limited | Novel compounds |
| WO2011067365A1 (en) | 2009-12-03 | 2011-06-09 | Glaxo Group Limited | Benzpyrazole derivatives as inhibitors of p13 kinases |
| JP2013512880A (ja) | 2009-12-03 | 2013-04-18 | グラクソ グループ リミテッド | Ｐｉ３−キナーゼ阻害剤としてのインダゾール誘導体 |
| WO2011110575A1 (en) | 2010-03-11 | 2011-09-15 | Glaxo Group Limited | Derivatives of 2-[2-(benzo- or pyrido-) thiazolylamino]-6-aminopyridine, useful in the treatment of respiratoric, allergic or inflammatory diseases |
| RS54286B1 (sr) | 2010-09-08 | 2016-02-29 | Glaxosmithkline Intellectual Property Development Limited | Polimorfi i soli n-[5-[4-(5-{[(2r,6s)-2,6-dimetil-4-morfolinil]metil}-1,3-oksazol-2-il)-1h-indazol-6-il]-2(metiloksi)-3-piridinil]-metansulfonamida |
| WO2012035055A1 (en) | 2010-09-17 | 2012-03-22 | Glaxo Group Limited | Novel compounds |
| GB201018124D0 (en) | 2010-10-27 | 2010-12-08 | Glaxo Group Ltd | Polymorphs and salts |
| CN104470503A (zh) | 2012-04-13 | 2015-03-25 | 葛兰素史克知识产权开发有限公司 | 聚集粒子 |
| GB201222679D0 (en) | 2012-12-17 | 2013-01-30 | Glaxo Group Ltd | Pharmaceutical combination products |
| WO2015055691A1 (en) | 2013-10-17 | 2015-04-23 | Glaxosmithkline Intellectual Property Development Limited | Pi3k inhibitor for treatment of respiratory disease |
| RU2016112268A (ru) | 2013-10-17 | 2017-11-22 | Глаксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед | Ингибитор PI3K для лечения респираторного заболевания |
| US20170100385A1 (en) | 2014-05-12 | 2017-04-13 | Glaxosmithkline Intellectual Property (No. 2) Limited | Pharmaceutical compositions comprising danirixin for treating infectious diseases |
| GB201602527D0 (en) | 2016-02-12 | 2016-03-30 | Glaxosmithkline Ip Dev Ltd | Chemical compounds |
| US20190161480A1 (en) | 2016-08-08 | 2019-05-30 | Glaxosmithkline Intellectual Property Development Limited | Chemical Compounds |
| GB201706102D0 (en) | 2017-04-18 | 2017-05-31 | Glaxosmithkline Ip Dev Ltd | Chemical compounds |
| GB201712081D0 (en) | 2017-07-27 | 2017-09-13 | Glaxosmithkline Ip Dev Ltd | Chemical compounds |
| WO2021191875A1 (en) | 2020-03-26 | 2021-09-30 | Glaxosmithkline Intellectual Property Development Limited | Cathepsin inhibitors for preventing or treating viral infections |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2800481A (en) * | 1955-07-01 | 1957-07-23 | Smith Kline French Lab | Tertiary alcohol derivatives of 8-alkylnortropanes and the acid and quaternary ammonium salts thereof |
| US2800478A (en) * | 1955-07-01 | 1957-07-23 | Smith Kline French Lab | 3-substituted-8-alkylnortropanes and the acid and quaternary ammonium salts thereof |
| US2800482A (en) * | 1955-07-01 | 1957-07-23 | Smith Kline French Lab | Olefinic derivatives of 8-alkylnortropanes and the acid and quaternary ammonium salts thereof |
| AT298118B (de) | 1967-06-08 | 1972-04-25 | Siemens Ag | Verfahren zur Umsetzung von Spannungen in digitale Werte und Vorrichtung zur Durchführung des Verfahrens |
| GB2064336B (en) | 1979-12-06 | 1984-03-14 | Glaxo Group Ltd | Device for dispensing medicaments |
| DE3274065D1 (de) | 1981-07-08 | 1986-12-11 | Draco Ab | Powder inhalator |
| GB2169265B (en) | 1982-10-08 | 1987-08-12 | Glaxo Group Ltd | Pack for medicament |
| GB2129691B (en) | 1982-10-08 | 1987-08-05 | Glaxo Group Ltd | Devices for administering medicaments to patients |
| AU591152B2 (en) | 1985-07-30 | 1989-11-30 | Glaxo Group Limited | Devices for administering medicaments to patients |
| IT1204826B (it) | 1986-03-04 | 1989-03-10 | Chiesi Farma Spa | Composizioni farmaceutiche per inalazione |
| GB8923590D0 (en) * | 1989-10-19 | 1989-12-06 | Pfizer Ltd | Antimuscarinic bronchodilators |
| GB9000304D0 (en) * | 1990-01-06 | 1990-03-07 | Pfizer Ltd | Muscarinic receptor antagonists |
| GB9004781D0 (en) | 1990-03-02 | 1990-04-25 | Glaxo Group Ltd | Device |
| DE4108393A1 (de) * | 1991-03-15 | 1992-09-17 | Boehringer Ingelheim Kg | Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln |
| JP3294961B2 (ja) * | 1993-12-10 | 2002-06-24 | 杏林製薬株式会社 | 新規イミダゾール誘導体及びその製造法 |
| JPH08291141A (ja) * | 1995-04-21 | 1996-11-05 | Kotobuki Seiyaku Kk | ジフェニル酢酸誘導体及びその製造法 |
| JPH0920758A (ja) * | 1995-07-06 | 1997-01-21 | Kyorin Pharmaceut Co Ltd | 新規環状ジアミン誘導体及びその製造法 |
| US6350758B1 (en) | 1996-12-02 | 2002-02-26 | Georgetown University | Tropane derivatives and method for their synthesis |
| US6248752B1 (en) | 1998-02-27 | 2001-06-19 | Charles Duane Smith | Azabicyclooctane compositions and methods for enhancing chemotherapy |
| US6262066B1 (en) | 1998-07-27 | 2001-07-17 | Schering Corporation | High affinity ligands for nociceptin receptor ORL-1 |
| ES2165768B1 (es) | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. |
| CN1571787A (zh) * | 2001-10-17 | 2005-01-26 | Ucb公司 | 奎宁环衍生物、制备它们的方法和它们作为m2和/或m3毒蕈碱受体抑制剂的用途 |
| US6696462B2 (en) | 2002-01-31 | 2004-02-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Anticholinergics, processes for the preparation thereof, and pharmaceutical compositions |
| DE10211700A1 (de) * | 2002-03-16 | 2003-09-25 | Boehringer Ingelheim Pharma | Neue Difurylglykolsäureester, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel |
| TW200410951A (en) | 2002-08-06 | 2004-07-01 | Glaxo Group Ltd | M3 muscarinic acetylcholine receptor antagonists |
| EP1613307A4 (en) | 2003-04-07 | 2008-03-12 | Glaxo Group Ltd | M SB 3 / SB MUSCARIN ACETYLCHOLINE RECEPTOR ANTAGONISTS |
| TW200523261A (en) | 2003-07-17 | 2005-07-16 | Glaxo Group Ltd | Muscarinic acetylcholine receptor antagonists |
| PE20050250A1 (es) | 2003-07-17 | 2005-04-08 | Glaxo Group Ltd | Antagonistas de los receptores muscarinicos de la acetilcolina |
| PE20050711A1 (es) | 2003-07-17 | 2005-09-10 | Glaxo Group Ltd | Compuestos 8-azoniabiciclo[3.2.1] octanos como antagonistas de los receptores muscarinicos de la acetilcolina |
| WO2005037280A1 (en) * | 2003-10-14 | 2005-04-28 | Glaxo Group Limited | Muscarinic acetycholine receptor antagonists |
| PE20050489A1 (es) * | 2003-11-04 | 2005-09-02 | Glaxo Group Ltd | Antagonistas de receptores de acetilcolina muscarinicos |
| ES2329586T3 (es) * | 2003-11-21 | 2009-11-27 | Theravance, Inc. | Compuestos que tienen actividad agonista del receptor beta2 adrenergico y antagonista del receptor muscarino. |
| WO2006050239A2 (en) | 2004-10-29 | 2006-05-11 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
| WO2006055553A2 (en) | 2004-11-15 | 2006-05-26 | Glaxo Group Limited | Novel m3 muscarinic acetylcholine receptor antagonists |
| WO2006055503A2 (en) | 2004-11-15 | 2006-05-26 | Glaxo Group Limited | Novel m3 muscarinic acetylcholine receptor antagonists |
| PE20060826A1 (es) | 2004-12-06 | 2006-10-08 | Smithkline Beecham Corp | Derivado oleofinico de 8-azoniabiciclo[3.2.1]octano y combinacion farmaceutica que lo comprende |
| PE20061162A1 (es) | 2004-12-06 | 2006-10-14 | Smithkline Beecham Corp | Compuestos derivados olefinicos de 8-azoniabiciclo[3.2.1]octanos |
| WO2006065755A2 (en) | 2004-12-13 | 2006-06-22 | Glaxo Group Limited | Quaternary ammonium salts of fused hetearomatic amines as novel muscarinic acetylcholine receptor antagonists |
| WO2006065788A2 (en) | 2004-12-13 | 2006-06-22 | Glaxo Group Limited | Novel muscarinic acetylcholine receptor antagonists |
| WO2007018508A1 (en) | 2005-07-28 | 2007-02-15 | Glaxo Group Limited | Novel m3 muscarinic acetycholine receptor antagonists |
| WO2007018514A1 (en) | 2005-07-28 | 2007-02-15 | Glaxo Group Limited | Novel m3 muscarinic acetylcholine receptor antagonists |
| EP1937267A4 (en) | 2005-08-02 | 2009-08-26 | Glaxo Group Ltd | M3-MUSCARIN ACETYLCHOLIN RECEPTOR ANTAGONISTS |
| US20080234315A1 (en) | 2005-08-02 | 2008-09-25 | Jakob Busch-Petersen | M3 Muscarinic Acetylcholine Receptor Antagonists |
| WO2007022351A2 (en) | 2005-08-18 | 2007-02-22 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
-
2004
- 2004-10-12 WO PCT/US2004/033638 patent/WO2005037280A1/en not_active Ceased
- 2004-10-12 CA CA2542657A patent/CA2542657C/en not_active Expired - Fee Related
- 2004-10-12 TW TW096137867A patent/TW200811171A/zh unknown
- 2004-10-12 AP AP2006003566A patent/AP1828A/xx active
- 2004-10-12 EA EA200600773A patent/EA200600773A1/ru not_active IP Right Cessation
- 2004-10-12 EA EA200702619A patent/EA013689B1/ru not_active IP Right Cessation
- 2004-10-12 TW TW093130797A patent/TWI409060B/zh not_active IP Right Cessation
- 2004-10-12 NZ NZ556424A patent/NZ556424A/en not_active IP Right Cessation
- 2004-10-12 EP EP04794886A patent/EP1677795B1/en not_active Expired - Lifetime
- 2004-10-12 AR ARP040103693A patent/AR046103A1/es not_active Application Discontinuation
- 2004-10-12 TW TW096137868A patent/TW200811172A/zh unknown
- 2004-10-12 JP JP2006535591A patent/JP2007508390A/ja active Pending
- 2004-10-12 ES ES04794886T patent/ES2358673T3/es not_active Expired - Lifetime
- 2004-10-12 HR HR20110232T patent/HRP20110232T1/hr unknown
- 2004-10-12 AP AP2007004238A patent/AP2007004238A0/xx unknown
- 2004-10-12 MY MYPI20044177A patent/MY143366A/en unknown
- 2004-10-12 UA UAA200900439A patent/UA89734C2/ru unknown
- 2004-10-12 MX MXPA06004244A patent/MXPA06004244A/es active IP Right Grant
- 2004-10-12 AU AU2004281724A patent/AU2004281724B2/en not_active Ceased
- 2004-10-12 PE PE2004000982A patent/PE20050963A1/es not_active Application Discontinuation
- 2004-10-12 KR KR1020087016103A patent/KR20080067023A/ko not_active Ceased
- 2004-10-12 PL PL04794886T patent/PL1677795T3/pl unknown
- 2004-10-12 US US10/575,839 patent/US7276521B2/en not_active Expired - Fee Related
- 2004-10-12 KR KR1020087016101A patent/KR20080065318A/ko not_active Ceased
- 2004-10-12 DK DK04794886.4T patent/DK1677795T3/da active
- 2004-10-12 NZ NZ546312A patent/NZ546312A/en not_active IP Right Cessation
- 2004-10-12 CN CNA2008100092898A patent/CN101230061A/zh active Pending
- 2004-10-12 SG SG200807641-6A patent/SG147436A1/en unknown
- 2004-10-12 PT PT04794886T patent/PT1677795E/pt unknown
- 2004-10-12 OA OA1200600122A patent/OA13316A/en unknown
- 2004-10-12 EA EA200702617A patent/EA013435B1/ru not_active IP Right Cessation
- 2004-10-12 AP AP2007004239A patent/AP2007004239A0/xx unknown
- 2004-10-12 SI SI200431631T patent/SI1677795T1/sl unknown
- 2004-10-12 AT AT04794886T patent/ATE494285T1/de active
- 2004-10-12 CN CNA2004800372668A patent/CN1893948A/zh active Pending
- 2004-10-12 BR BRPI0415361-8A patent/BRPI0415361A/pt not_active Application Discontinuation
- 2004-10-12 KR KR1020067007082A patent/KR20060106821A/ko not_active Ceased
- 2004-10-12 CN CNA2008100092900A patent/CN101230062A/zh active Pending
- 2004-10-12 UA UAA200604113A patent/UA87473C2/ru unknown
- 2004-10-12 DE DE602004030930T patent/DE602004030930D1/de not_active Expired - Lifetime
-
2006
- 2006-03-31 EC EC2006006468A patent/ECSP066468A/es unknown
- 2006-04-06 IL IL174843A patent/IL174843A0/en unknown
- 2006-04-25 MA MA28964A patent/MA28110A1/fr unknown
- 2006-05-05 IS IS8441A patent/IS2918B/is unknown
- 2006-05-08 NO NO20062042A patent/NO20062042L/no not_active Application Discontinuation
-
2007
- 2007-06-21 US US11/766,371 patent/US7576096B2/en not_active Expired - Fee Related
- 2007-06-21 US US11/766,318 patent/US7579361B2/en not_active Expired - Fee Related
- 2007-08-02 JP JP2007201718A patent/JP4796552B2/ja not_active Expired - Fee Related
- 2007-08-02 JP JP2007201719A patent/JP2007314567A/ja active Pending
- 2007-12-13 IL IL188112A patent/IL188112A/en not_active IP Right Cessation
-
2011
- 2011-03-30 CY CY20111100339T patent/CY1111364T1/el unknown
- 2011-05-16 JP JP2011109756A patent/JP5450509B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011162556A5 (https=) | ||
| HRP20110232T1 (hr) | Antagonisti muskarinskog acetilkolinskog receptora | |
| JP2013542940A5 (https=) | ||
| HRP20120775T1 (hr) | Antagonisti m3 muskarinskog acetilkolinskog receptora | |
| HRP20120832T1 (hr) | Antagonisti muskarinskih acetilkolinskih receptora | |
| JP2011520911A5 (https=) | ||
| JP2013531056A5 (https=) | ||
| JP2012517987A5 (ja) | 吸入用の医薬組成物のｆｐｄ特性を設定する方法 | |
| US20100329996A1 (en) | Novel Combination of Therapeutic Agents | |
| JP2014515351A5 (https=) | ||
| ES2759247T3 (es) | Antagonistas muscarínicos y combinaciones de estos para el tratamiento de enfermedades de las vías respiratorias en caballos | |
| PT2506844T (pt) | Combinações de um antagonista do recetor muscarínico e um agonista do adrenorrecetor beta-2 | |
| JP2015519356A5 (https=) | ||
| JP2016527220A5 (https=) | ||
| JP2007520508A5 (https=) | ||
| JP2016534088A5 (https=) | ||
| RU2006104854A (ru) | Антагонисты мускариновых ацетилхолиновых рецепторов | |
| RU2006129289A (ru) | Антагонисты мускариновых ацетилхолиновых рецепторов | |
| RU2006104851A (ru) | Антагонисты мускариновых рецепторов ацетилхолина | |
| JP2007522141A5 (https=) | ||
| JP2008531558A5 (https=) | ||
| JP2012532191A5 (https=) | ||
| JP2014511897A5 (https=) | ||
| JP2014518894A (ja) | ウメクリジニウムを含む乾燥粉末インヘラー組成物 | |
| JP2016506946A (ja) | 吸入療法用の多成分結晶粒子 |